Al-Dawaa Medical Services Company

SASE:4163 株式レポート

時価総額:ر.س7.5b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Al-Dawaa Medical Services 将来の成長

Future 基準チェック /36

Al-Dawaa Medical Services利益と収益がそれぞれ年間13.5%と6.4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に30.8% 12.7%なると予測されています。

主要情報

13.5%

収益成長率

12.7%

EPS成長率

Consumer Retailing 収益成長9.9%
収益成長率6.4%
将来の株主資本利益率30.8%
アナリストカバレッジ

Low

最終更新日06 Jun 2024

今後の成長に関する最新情報

Recent updates

Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Jun 03
Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

May 08
Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality

Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Apr 05
Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns

Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Dec 26
Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger

Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Sep 03
Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25

Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Jul 13
Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 22
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value

Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Apr 10
Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)

Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Mar 14
Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio

Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

Dec 08
Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?

業績と収益の成長予測

SASE:4163 - アナリストの将来予測と過去の財務データ ( )SAR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20267,0525184878264
12/31/20256,6044714968105
12/31/20246,2074004768125
3/31/20245,850348597836N/A
12/31/20235,741329502726N/A
9/30/20235,742326703847N/A
6/30/20235,612303715880N/A
3/31/20235,485295529743N/A
12/31/20225,372305528778N/A
9/30/20225,212285266651N/A
6/30/20225,163275142519N/A
3/31/20225,119247217561N/A
12/31/20215,034239361670N/A
9/30/20214,977254413649N/A
6/30/20214,958300400644N/A
3/31/20214,932286348566N/A
12/31/20204,962246166378N/A
12/31/20193,962233356515N/A
12/31/20183,797228244392N/A
12/31/20173,376121N/A568N/A

アナリストによる今後の成長予測

収入対貯蓄率: 4163の予測収益成長率 (年間13.5% ) は 貯蓄率 ( 14.3% ) を下回っています。

収益対市場: 4163の収益 ( 13.5% ) はSA市場 ( 6.8% ) よりも速いペースで成長すると予測されています。

高成長収益: 4163の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 4163の収益 ( 6.4% ) SA市場 ( -0.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: 4163の収益 ( 6.4% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: 4163の 自己資本利益率 は、3年後には高くなると予測されています ( 30.8 %)


成長企業の発掘